EssilorLuxottica S.A. (ESLOY) est une société cotée en bourse dans le Santé secteur, opérant dans le Medical - Instruments & Supplies secteur d'activité. Le siège social de l'entreprise est situé à Paris, France. Le PDG actuel est Francesco Milleri.
ESLOY a date d'introduction en bourse 2008-01-30, 153,498 employés à temps plein, cotée sur le Other OTC, une capitalisation boursière de $111.1B.
EssilorLuxottica S.A. is a global leader in ophthalmic products, designing, manufacturing, and distributing eyewear across six continents. The company operates through five business segments: Wholesale and Retail (luxury and sports eyewear brands), Lenses and Optical Instruments (including premium lens technologies such as Varilux, Crizal, Transitions, and Eyezen), Equipment (digital surfacing and coating machines), and Sunglasses and Readers (non-prescription eyewear under brands like Foster Grant and licensed labels). With a network of 490 prescription laboratories and edging-mounting facilities worldwide, EssilorLuxottica serves opticians, eye care professionals, and consumers through both wholesale and direct retail channels. The company was formed through the 2018 merger of Essilor International and Luxottica.
